TechFDA's Elsa AI Hallucinates Studies, Says Employees: Double-Checking Facts Is a Must The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.by Isaiah Richard
TechFDA, OpenAI Reportedly Discussing the Use of AI for Drug Evaluations Under cderGPT Projectby Isaiah Richard
TechFDA Approves New Alzheimer's Drug, Bringing Hope of Slowing Disease for US Patientsby Inno Flores
TechSalmonella Outbreak in Cucumbers Linked to Untreated Water Used by Florida Grower, Health Officials Sayby Inno Flores
HealthHims & Hers Selling Affordable Weight Loss Drugs Not Approved by FDA: Here's the Risksby Quincy Jon